Colorectal cancer in middle-aged women in relation to hormonal status: A report from the Women's Health in the Lund Area (WHILA) study

Gynecological Endocrinology

Volumn 22, Issue 8, 2006, Pages 416-422

  Nazeri, Kavoos ^a,c   Khatibi, Ali ^a   Nyberg, Per ^b   Agardh, Carl David ^b   Lidfeldt, Jonas ^b   Samsioe, Goran ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Colorectal cancer; Estrogen monotherapy; Hormone therapy; Middle aged women; Progesterone

Indexed keywords

ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; GESTAGEN;

ADULT; ARTICLE; CANCER RISK; COLORECTAL CANCER; ESTROGEN THERAPY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; PARITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SWEDEN;

ADENOCARCINOMA; BODY MASS INDEX; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; QUESTIONNAIRES; SWEDEN; WOMEN'S HEALTH;

EID: 33749458428     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590600900378     Document Type: Article

References (38)

1. Levin B. Neoplasm of the large and small intestine. In: Goldman L, Benneth JC, editors. Cecil text book of medicine. 21st ed. Philadelphia (PA): Saunders; 2000. pp 741-742.
2. Thörn M, Bergström R, Kressner U, Sparen P, Zack M, Ekbom A. Trends in colorectal cancer incidence in Sweden 1959-93 by gender, localization, time period, and birth cohort. Cancer Causes Control 1998;9:145-152.
3. Hakama M, Hoff G, Kronborg O, Pahlman L. Screening for colorectal cancer. Acta Oncol 2005;44:425-439.
4. Birgisson H, Talback M, Gunnarsson U, Pahlman L, Glimelius B. Improved survival in cancer of colon and rectum in Sweden. Eur J Surg Oncol 2005;31:845-853.
5. Anon. Colorectal cancer. In: Beers M, Berkow R, editors. The Merck manual of diagnosis and therapy. 17th ed. Rahway, NJ: Merck Research Laboratories; 1999. pp 328-330.
6. Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN, Anderson K, Schaffer D, Samowitz WS. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 2001;61:126-130.
7. Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006;55: 285-291.
8. Hou L, Ji BT, Blair A, Dai Q, Gao YT, Potter JD, Chow WH. Body mass index and colon cancer risk in Chinese people: menopause as an effect modifier. Eur J Cancer 2006;42: 84-90.
9. Gerhardsson M, Floderus B, Norell SE. Physical activity and colon cancer risk. Int J Epidemiol 1988;17:728-729.
10. Gerhardsson M, Steineck G, Norell SE. Colorectal cancer in Sweden. A descriptive epidemiologic study. Acta Oncol 1990;29:855-861.
11. Park SK, Joo JS, Kim DH, Kim YE, Kang D, Yoo KY. Association of serum lipids and glucose with the risk of colorectal adenomatous polyp in men: a case-control study in Korea. J Korean Med Sci 2000;15:690-695.
12. Suzuki K, Ito Y, Wakai K, Kawado M, Hashimoto S, Toyoshima H, Kojima M, Tokudome S, Hayakawa N, Watanabe Y, et al. Japan Collaborative Cohort Study Group. Serum oxidized low-density lipoprotein levels and risk of colorectal cancer: a case-control study nested in Japan Collaborative Cohort Study. Cancer Epidemiol Biomarkers Prev 2004;13:1781-1787.
13. Shemerovskii KA. [Constipation - a risk factor for the colorectal cancer]. Klin Med (Mosk) 2005;83:60-64.
14. Chen K, Qui JL, Zhang Y, Zhao YW. Meta analysis of risk factors for colorectal cancer. World J Gastroenterol 2003;9: 1589-1600.
15. Terry P, Ekbom A, Lichtenstein P, Feychting M, Wolk A. Long-term tobacco smoking and colorectal cancer in a prospective cohort study. Int J Cancer 2001;91:585-587.
16. Engeland A, Andersen A, Haldorsen T, Tretli S. Smoking habits and risk of cancers other than lung cancer: 28 years' follow-up of 26,000 Norwegian men and women. Cancer Causes Control 1996;7:497-506.
17. Jassam N, Bell SM, Speirs V, Quirke P. Loss of expression of oestrogen receptor b in colon cancer and its association with Dukes' staging. Oncol Rep 2005;14:17-21.
18. Korenaga D, Orita H, Maekawa S, Itasaka H, Ikeda T, Sugimachi K. Relationship between hormone receptor levels and cell-kinetics in human colorectal cancer. Hepatogastroenterology 1997;44:78-83.
19. Bassalyk LS, Korotkova TV, Prorokov VV, Murav'eva NI, Smirnova KD. [Prognostic value of the level of steroid hormone receptors in cancer of the large intestine]. Vopr Onkol 1987;33:43-46.
20. Burkman RT. Reproductive hormones and cancer: ovarian and colon cancer. Obstet Gynecol Clin North Am 2002;29: 527-540.
21. Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control 1997;8:146-158.
22. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review of meta-analysis. Am J Med 1999;106:574-582.
23. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-333.
24. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, et al. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2004; 291:1701-1712.
25. Lidfeldt J, Nyberg P, Nerbrand C, Ojehagen A, Samsioe G, Schersten B, Agardh CD. Biological factors are more important than socio-demographic and psychosocial conditions in relation to hypertension in middle-aged women. The Women's Health in the Lund Area (WHILA) study. Blood Press 2002;11:270-278.
26. Li C, Wilawan K, Samsioe G, Lidfeldt J, Agardh CD, Nerbrand C. Health profile of middle-aged women: the Women's Health in the Lund Area (WHILA) study. Hum Reprod 2002;17:1379-1385.
27. Lidfeldt J, Nerbrand C, Samsioe G. Women's Health in the Lund Area (WHILA) study. In: Schneider HPG, Naftolin F, editors. Climacteric medicine - Where do we go? Abingdon: Taylor and Francis; 2005. pp 36-48.
28. Jernstrom H, Bendahl PO, Lidfeldt J, Nerbrand C, Agardh CD, Samsioe G. A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the Women's Health in the Lund Area (WHILA) study (Sweden). Cancer Causes Control 2003;14:673-680.
29. Lidfeldt J, Nyberg P, Nerbrand C, Samsioe G, Schersten B, Agardh CD. Socio-demographic and psychological factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study. Diabetes Obes Metab 2003;5:106-112.
30. Shakir Y, Samsioe G, Nyberg P, Lidfeldt J, Nerbrand C. Cardiovascular risk factors in middle-aged women and association with use of hormone therapy: results from a population-based study of the Swedish women. The Women's Health in the Lund Area (WHILA) Study. Climacteric 2004;7:274-283.
31. Persson I, Yuen J, Bergkvist L, Schairer C. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy - long-term follow-up of Swedish cohort. Int J Cancer 1996;67:327-332.
32. Talamini R, Franceschi S, Dal Maso L, Negri E, Conti E, Filiberti R, Montella M, Nanni O, La Vecchia C. The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women. Eur J Cancer 1998;34: 1070-1076.
33. Nichols HB, Trentham-Dietz A, Hampton JM, Newcomb PA. Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin. Cancer Epidemiol Biomarkers Prev 2005;14:1212-1218.
34. Chute CG, Willett WC, Colditz GA, Stampfer MJ, Rosner B, Speizer FE. A prospective study of reproductive history and exogenous estrogen on the risk of colorectal cancer in women. Epidemiology 1991;2:201-207.
35. Ghatge RP, Jacobsen BM, Schittone SA, Horwitz KB. The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells. Breast Cancer Res 2005;7: R1036-R1050.
36. Schoonen WG, Deckers GH, De Gooijer ME, de Ries R, Kloosterboer HJ. Hormonal properties of norethisterone, 7α-methyl-norethisterone and their derivatives. J Steroid Biochem Mol Biol 2000;74:213-222.
37. Cagnacci A, De Toni A, Caretto S, Menozzi R, Bondi M, Corradini B, Alessandrini C, Volpe A. Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women. Menopause 2006; 13:197-201.
38. Grodstein F, Martinez ME, Platz EA, Giovannucci E, Colditz GA, Kautzky M, Fuchs C, Stampfer MJ. Postmenopausal hormone use and the risk of colorectal adenoma and cancer. Ann Intern Med 1998;128:705-712.